Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Insiders Menu
Roster
Transactions
Neoleukin Therapeutics, Inc. (AQXP)
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
10/05/2023
BAKER BROS. ADVISORS LP
10% Owner
Exercise (in-the-money or at-the-money)
Pre-funded Warrants
57k
$0.00
$0
See Footnotes
10/05/2023
10/05/2023
BAKER BROS. ADVISORS LP
10% Owner
Exercise (in-the-money or at-the-money)
Pre-funded Warrants
535.6k
$0.00
$0
See Footnotes
10/05/2023
08/17/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
7.7k
$0.69
$5.3k
See Footnotes
08/15/2023
08/17/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
93.1k
$0.69
$64.5k
See Footnotes
08/15/2023
08/17/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
5k
$0.69
$3.5k
See Footnotes
08/15/2023
08/17/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
61.1k
$0.69
$42.4k
See Footnotes
08/15/2023
08/16/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
17.1k
$0.68
$11.7k
See Footnotes
08/15/2023
08/16/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
207.7k
$0.68
$141.3k
See Footnotes
08/15/2023
08/16/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
366
$0.68
$249.9
See Footnotes
08/15/2023
08/16/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
4.4k
$0.68
$3k
See Footnotes
08/15/2023
08/15/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
143.5k
$0.63
$90.5k
See Footnotes
08/15/2023
08/15/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
1.7M
$0.63
$1.1M
See Footnotes
08/15/2023
08/15/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
358
$0.67
$238.1
See Footnotes
08/15/2023
08/15/2023
BAKER BROS. ADVISORS LP
10% Owner
Purchase
Common Stock
4.3k
$0.67
$2.9k
See Footnotes
08/15/2023
08/11/2023
Smith Sean Michael
Interim CFO, Prin Acct Off
Sale
Common Stock
1.3k
$0.62
$818.1
08/10/2023
08/10/2023
Smith Sean Michael
Interim CFO, Prin Acct Off
Exercise
Restricted Stock Units
5k
$0.00
$0
08/10/2023
06/08/2023
BAKER BROS. ADVISORS LP
10% Owner
Grant
Non-Qualified Stock Option (right to buy)
25k
$0.79
$19.8k
See Footnotes
06/08/2023
06/08/2023
Noonberg Sarah B.
Director
Grant
Stock Option (Right to Buy)
25k
$0.79
$19.8k
06/08/2023
06/08/2023
Lavelle Erin
Director
Grant
Stock Option (Right to Buy)
25k
$0.79
$19.8k
06/08/2023
06/08/2023
PALEKAR ROHAN
Director
Grant
Stock Option (Right to Buy)
25k
$0.79
$19.8k
06/08/2023
06/08/2023
SIMPSON TODD E
Director
Grant
Stock Option (Right to Buy)
25k
$0.79
$19.8k
06/08/2023
06/08/2023
Babler Martin
Director
Grant
Stock Option (Right to Buy)
25k
$0.79
$19.8k
06/08/2023
04/03/2023
Patel Priti
Sale
Common Stock
3.8k
$0.69
$2.6k
03/31/2023
03/31/2023
Patel Priti
Exercise
Restricted Stock Units
10k
$0.00
$0
03/31/2023
08/10/2022
Smith Sean Michael
Interim CFO, Prin Acct Off
Sale
Common Stock
1.7k
$0.99
$1.6k
08/10/2022
08/10/2022
Smith Sean Michael
Interim CFO, Prin Acct Off
Exercise
Restricted Stock Units
5k
$0.00
$0
08/10/2022
08/02/2022
Patel Priti
Grant
Stock Option (Right to Buy)
250k
$0.99
$247.5k
08/02/2022
08/02/2022
Smith Sean Michael
Interim CFO, Prin Acct Off
Grant
Stock Option (Right to Buy)
150k
$0.99
$148.5k
08/02/2022
08/02/2022
Walkey Carl
Senior Vice President
Grant
Stock Option (Right to Buy)
150k
$0.99
$148.5k
08/02/2022
08/02/2022
Cochener Donna
General Counsel, SVP Legal
Grant
Stock Option (Right to Buy)
100k
$0.99
$99k
08/02/2022
08/02/2022
DRACHMAN JONATHAN G
President and CEO
Grant
Stock Option (Right to Buy)
350k
$0.99
$346.5k
08/02/2022
05/12/2022
Babler Martin
Director
Grant
Stock Option (Right to Buy)
25k
$1.07
$26.8k
05/12/2022
05/12/2022
Noonberg Sarah B.
Director
Grant
Stock Option (Right to Buy)
25k
$1.07
$26.8k
05/12/2022
05/12/2022
Lavelle Erin
Director
Grant
Stock Option (Right to Buy)
25k
$1.07
$26.8k
05/12/2022
05/12/2022
PALEKAR ROHAN
Director
Grant
Stock Option (Right to Buy)
25k
$1.07
$26.8k
05/12/2022
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy